首页> 外文期刊>Immunity >A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewis(x), an L-selectin ligand displayed by CD34.
【24h】

A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewis(x), an L-selectin ligand displayed by CD34.

机译:一种新型的,高内皮微静脉特异性的磺基转移酶表达6-磺酰唾液酸的Lewis(x),一种CD34展示的L-选择蛋白配体。

获取原文
获取原文并翻译 | 示例
           

摘要

L-selectin mediates lymphocyte homing by facilitating lymphocyte adhesion to unique carbohydrate ligands, sulfated sialyl Lewis(x), which are expressed on high endothelial venules (HEV) in secondary lymphoid organs. The nature of the sulfotransferase(s) that contribute to sulfation of such L-selectin counterreceptors has been uncertain. We herein describe a novel L-selectin ligand sulfotransferase, termed LSST, that directs the synthesis of the 6-sulfo sialyl Lewis(x) on L-selectin counterreceptors CD34, GlyCAM-1, and MAdCAM-1. LSST is predominantly expressed in HEV and exhibits striking catalytic preference for core 2-branched mucin-type O-glycans as found in natural L-selectin counterreceptors. LSST enhances L-selectin-mediated adhesion under shear compared to nonsulfated controls. LSST therefore corresponds to an HEV-specific sulfotransferase that contributes to the biosynthesis of L-selectin ligands required for lymphocyte homing.
机译:L-选择蛋白通过促进淋巴细胞粘附于独特的碳水化合物配体硫酸盐唾液酸Lewis(x)介导淋巴细胞归巢,所述碳水化合物在次级淋巴器官的高内皮小静脉(HEV)上表达。导致这种L-选择蛋白抗受体硫酸化的磺基转移酶的性质尚不确定。我们在本文中描述了一种新型的L-选择蛋白配体磺基转移酶,称为LSST,它指导L-选择蛋白抗受体CD34,GlyCAM-1和MAdCAM-1上的6磺基唾液酸Lewis(x)的合成。 LSST主要在HEV中表达,并且对天然L-选择蛋白抗受体中发现的核心2支粘蛋白型O型聚糖具有明显的催化偏好。与非硫酸盐对照组相比,LSST在剪切作用下增强了L-选择蛋白介导的粘附。因此,LSST对应于HEV特异性磺基转移酶,其有助于淋巴细胞归巢所需的L-选择蛋白配体的生物合成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号